DE60005164D1 - Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion - Google Patents

Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion

Info

Publication number
DE60005164D1
DE60005164D1 DE60005164T DE60005164T DE60005164D1 DE 60005164 D1 DE60005164 D1 DE 60005164D1 DE 60005164 T DE60005164 T DE 60005164T DE 60005164 T DE60005164 T DE 60005164T DE 60005164 D1 DE60005164 D1 DE 60005164D1
Authority
DE
Germany
Prior art keywords
sialyl
fucosilized
sialilated
lewis
bacterial adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60005164T
Other languages
English (en)
Inventor
Thomas Boren
Lennart Hammarstroem
Karl-Anders Karlsson
Susann Teneberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60005164D1 publication Critical patent/DE60005164D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60005164T 1999-03-19 2000-03-16 Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion Expired - Lifetime DE60005164D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9901007A SE9901007D0 (sv) 1999-03-19 1999-03-19 Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
PCT/SE2000/000514 WO2000056343A1 (en) 1999-03-19 2000-03-16 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence

Publications (1)

Publication Number Publication Date
DE60005164D1 true DE60005164D1 (de) 2003-10-16

Family

ID=20414923

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60005164T Expired - Lifetime DE60005164D1 (de) 1999-03-19 2000-03-16 Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion

Country Status (7)

Country Link
EP (1) EP1169044B1 (de)
JP (1) JP2002539266A (de)
AT (1) ATE249227T1 (de)
AU (1) AU4155700A (de)
DE (1) DE60005164D1 (de)
SE (1) SE9901007D0 (de)
WO (1) WO2000056343A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066502A1 (en) * 2001-02-21 2002-08-29 Boren Thomas Helicobacter pylori sialic acid binding adhesin, saba and saba - gene
FI20011403A (fi) * 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
US20040176320A1 (en) * 2001-06-29 2004-09-09 Jari Natunen Use of at least one glycoinhibitor substance
WO2003089450A2 (en) * 2002-04-22 2003-10-30 Recopharma Ab Fusion polypeptides and methods for inhibiting microbial adhesion
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
EP2692740A1 (de) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Glycanzusammensetzungen, Verfahren zu deren Herstellung und deren Verwendungen als Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK76193D0 (da) * 1993-06-25 1993-06-25 Astra Ab Kulhydratderivater
AU709149B2 (en) * 1994-03-02 1999-08-19 Neose Technologies, Inc. Method for treating and inhibiting gastric and duodenal ulcers

Also Published As

Publication number Publication date
EP1169044A1 (de) 2002-01-09
SE9901007D0 (sv) 1999-03-19
EP1169044B1 (de) 2003-09-10
JP2002539266A (ja) 2002-11-19
AU4155700A (en) 2000-10-09
WO2000056343A1 (en) 2000-09-28
ATE249227T1 (de) 2003-09-15

Similar Documents

Publication Publication Date Title
RÖLLA Why is sucrose so cariogenic? The role of glucosyltransferase and polysaccharides
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
MXPA05000880A (es) Probioticos para funciones neuromusculares del intestino.
CA2460749A1 (en) Glycoconjugate vaccines for use in immune-compromised populations
EP3326634A3 (de) Zusammensetzung zur anregung der darmflora in neugeborenen, die durch kayserschnitt geboren wurden
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BR0206689A (pt) Combinação de probióticos, e, uso desta
NO20060498L (no) Metode for a promotere benvekst
BR0112685A (pt) Composição nutricional
Stege et al. Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori
Seltzer Pain in endodontics
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
SE9600716D0 (sv) Adhesion inhibitors, preparation comprising them and method for producing them
BRPI0410341A (pt) conjugados de polissacarìdeo-proteìna derivatizados de meningococos multivalente e vacina
MX2008001520A (es) Composiciones de tizanidina y metodos de tratamiento usando las composiciones.
IL173481A0 (en) Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration
EP1393734A4 (de) Arzneimittel gegen darmerkrankungen
DE60005164D1 (de) Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion
BRPI0416088A (pt) composição, sistema, e método de tratar condições tais como calcificação vascular
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
MD20060037A (ro) Metodă de tratament al hepatitei virale acute C
Robo et al. HBOT application at cases of gingival inflammation
Isler Doxycycline-induced esopageal ulceration
Vasil'ev Zantac (ranitidine) in treating duodenal ulcers
Kolesnikova et al. Clinical significance of" night acid burst" phenomenon in patients with duodenal ulcer

Legal Events

Date Code Title Description
8332 No legal effect for de